Merck & Co., Inc. (MRK) (JOBS) Starts Generic Arm to Copy Biologic Medicines
12/9/2008 7:06:59 AM
Bloomberg -- Merck & Co. will start a new unit to copy biotechnology medicines, increasing the drugmaker's stake in the $94 billion market for treatments based on living cells.
|